Agafonova O G, Vinogradov D V, Khaspekova S G, Lagutina N Ia, Labinskaia T A, Vasil'ev S A, Mazurov A V
Biull Eksp Biol Med. 1992 Dec;114(12):635-7.
Immunological methods were developed for the diagnosis of platelet membrane glycoprotein (GP) deficiencies. The number of membrane GP on platelet surface was determined as the binding of 125I-labeled monoclonal antibodies (mAB) directed against individual platelet GP. Total amount of GP in platelet lysate was assessed by immunoblotting with specific polyclonal antibodies. Methods were applied for patients with different thrombocytopathies. Binding of mAB VM16a, directed against GP IIb-IIIa was strongly decreased in patients with Glanzmann's thrombasthenia (0.5-14.5% of normal) and binding of anti-GP Ib mAB VM16d--in patient with Bernard-Soulier syndrome (0.5% of control) indicating the deficiencies of corresponding GP. In patient with gray platelet syndrome binding of both antibodies was not decreased but even increased. It was shown by immunoblotting that platelets from the patient with gray platelet syndrome contained normal amount of GP IIa, but strongly decreased amount of GMP-140 (14.5% of control)--membrane GP of platelet--granules.
已开发出免疫方法用于诊断血小板膜糖蛋白(GP)缺陷。血小板表面膜GP的数量通过针对单个血小板GP的125I标记单克隆抗体(mAB)的结合来确定。血小板裂解物中GP的总量通过用特异性多克隆抗体进行免疫印迹来评估。这些方法应用于患有不同血小板病的患者。针对GP IIb-IIIa的单克隆抗体VM16a在Glanzmann血小板无力症患者中的结合力显著降低(为正常水平的0.5 - 14.5%),而抗GP Ib单克隆抗体VM16d在Bernard-Soulier综合征患者中的结合力降低(为对照的0.5%),表明相应GP存在缺陷。在灰色血小板综合征患者中,两种抗体的结合力并未降低,反而有所增加。免疫印迹显示,灰色血小板综合征患者的血小板中GP IIa含量正常,但GMP-140(血小板颗粒的膜GP)含量显著降低(为对照的14.5%)。